Publications by authors named "Angus Forster"

Claim this Profile
W
White paper: Understanding, informing and defining the regulatory science of microneedle-based dosage forms that are applied to the skin.
Maria Dul, Mohammed Alali, Mahmoud Ameri, Matthew Douglas Burke, Benjamin Paul Creelman, Angus Harry Forster

J Control Release· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial.
Ben Baker, Imogen M Bermingham, Indika Leelasena, Julian Hickling, Paul R Young, Angus H Forster

Vaccines (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, safety, usability and acceptability of microarray patches for vaccination: a systematic review and meta-analysis.
Matthew N Berger, Ellen S Mowbray, Marian W A Farag, Erin Mathieu, Cristyn Davies, Angus H Forster

BMJ Glob Health· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) product.
Maria Dul, Mohammed Alali, Mahmoud Ameri, Matthew Douglas Burke, Christine M Craig, Angus Harry Forster

J Control Release· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usability, acceptability, and feasibility of a High-Density Microarray Patch (HD-MAP) applicator as a delivery method for vaccination in clinical settings.
Cristyn Davies, Melody Taba, Lucy Deng, Ceylan Karatas, Shopna Bag, Angus Forster

Hum Vaccin Immunother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities and challenges for commercializing microarray patches for vaccination from a MAP developer's perspective.
Angus Forster, Michael Junger

Hum Vaccin Immunother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial.
Alexandra C I Depelsenaire, Katey Witham, Margaret Veitch, James W Wells, Christopher D Anderson, Angus H Forster

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the Nanopatch Microneedle Delivery System.
Ying Wan, Vineet Gupta, Christopher Bird, Swathi R Pullagurla, Paul Fahey, Angus Forster

Hum Vaccin Immunother· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innate local response and tissue recovery following application of high density microarray patches to human skin.
David A Muller, Joakim Henricson, S Ben Baker, Totte Togö, Cesar M Jayashi Flores, Angus Forster

Sci Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Author Correction: M-protein based vaccine induces immunogenicity and protection from when delivered on a high-density microarray patch (HD-MAP).
Jamie-Lee S Mills, Cesar M Jayashi Flores, Simone Reynolds, Christine Wun, Ainslie Calcutt, Angus H Forster

NPJ Vaccines· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
M-protein based vaccine induces immunogenicity and protection from when delivered on a high-density microarray patch (HD-MAP).
Jamie-Lee S Mills, Cesar M Jayashi Flores, Simone Reynolds, Christine Wun, Ainslie Calcutt, Angus H Forster

NPJ Vaccines· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
Angus H Forster, Katey Witham, Alexandra C I Depelsenaire, Margaret Veitch, James W Wells

PLoS Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessment.
Brian K Meyer, Mark A F Kendall, Donna M Williams, Andrew J Bett, Sheri Dubey, Angus Forster

Vaccine X· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch™ Microprojection Array.
Ying Wan, John M Hickey, Christopher Bird, Katey Witham, Paul Fahey, Angus Forster

J Pharm Sci· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™).
Germain J P Fernando, Julian Hickling, Cesar M Jayashi Flores, Paul Griffin, Christopher D Anderson, Angus H Forster

Vaccine· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, acceptability and tolerability of uncoated and excipient-coated high density silicon micro-projection array patches in human subjects.
Paul Griffin, Suzanne Elliott, Kenia Krauer, Cristyn Davies, S Rachel Skinner, Angus Forster

Vaccine· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-density microprojection array delivery to rat skin of low doses of trivalent inactivated poliovirus vaccine elicits potent neutralising antibody responses.
David A Muller, Germain J P Fernando, Nick S Owens, Christiana Agyei-Yeboah, Jonathan C J Wei, Angus Forster

Sci Rep· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approaches to the physico-chemical and mechanical characterisation of functional coatings, Part II.
Angus Forster, Thomas Neudeck, Stephen Blatcher

Med Device Technol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melt extrusion and spray drying of carbamazepine and dipyridamole with polyvinylpyrrolidone/vinyl acetate copolymers.
James E Patterson, Michael B James, Angus H Forster, Thomas Rades

Drug Dev Ind Pharm· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling.
James E Patterson, Michael B James, Angus H Forster, Robert W Lancaster, James M Butler

Int J Pharm· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of indomethacin and nifedipine using variable-temperature solid-state NMR.
David C Apperley, Angus H Forster, Romain Fournier, Robin K Harris, Paul Hodgkinson

Magn Reson Chem· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds.
James E Patterson, Michael B James, Angus H Forster, Robert W Lancaster, James M Butler

J Pharm Sci· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis